PD-L1-IN-2
PD-L1-IN-2 is a potential tumor immunological agent by inhibiting PD-L1. PD-L1-IN-2 is a Naamidine J derivative and exerts antitumor effects in vivo by reducing PD-L1 expression and enhancing tumor-infiltrating T-cell immunity. PD-L1-IN-2 is used for colorectal cancer research[1].
Product Specifications
UNSPSC
12352005
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-l1-in-2.html
Purity
98.66
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
COC1=CC=C(CC2=C(CC3=CC(OC)=C(OC)C=C3)N(C)C(NC(C4=CC(NC(OC(C)(C)C)=O)=CC=C4)=O)=N2)C=C1
Molecular Formula
C33H38N4O6
Molecular Weight
586.68
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-149830/PD-L1-IN-2-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-149830/PD-L1-IN-2-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[2894733-91-4]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Keratin 7 (Keratin Type II Cytoskeletal 7, Keratin-7, K7, KRT7, Cytokeratin-7, CK7, CK-7, K2C7, MGC3625, MGC129731, Sarcolectin, SCL, Type-II Keratin Kb7) APC
Keratin 7 (Keratin Type II Cytoskeletal 7, Keratin-7, K7, KRT7, Cytokeratin-7, CK7, CK-7, K2C7, MGC3625, MGC129731, Sarcolectin, SCL, Type-II Keratin Kb7) APC